William M. Caldwell
Präsident bei Mytogen, Inc.
Profil
William M.
Caldwell is currently the President & Director at Mytogen, Inc. and a Director at King Koil Franchising Corp.
He was previously the Chairman & CEO at Astellas Institute for Regenerative Medicine from 2005 to 2010.
He also served as the CEO at CAIS Internet, Inc. and as a Director at Lee Pharmaceuticals.
Additionally, he was the President of Digital Satellite Broadcasting Corp.
Caldwell received his undergraduate degree from the University of Southern California.
Aktive Positionen von William M. Caldwell
| Unternehmen | Position | Beginn |
|---|---|---|
| King Koil Franchising Corp. | Direktor/Vorstandsmitglied | - |
Mytogen, Inc.
 Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Präsident | - |
Ehemalige bekannte Positionen von William M. Caldwell
| Unternehmen | Position | Ende |
|---|---|---|
| OCATA THERAPEUTICS INC | Vorstandsvorsitzender | 13.12.2010 |
| RONN INC. | Direktor/Vorstandsmitglied | - |
| Digital Satellite Broadcasting Corp. | Präsident | - |
CAIS Internet, Inc.
 CAIS Internet, Inc. Information Technology ServicesTechnology Services CAIS Internet, Inc. is a broadband access solutions provider for hotels, apartments, and small to medium-sized businesses. The private company is based in Washington. | Präsident | - |
Ausbildung von William M. Caldwell
| University of Southern California | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
Astellas Institute for Regenerative Medicine
 Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
| King Koil Franchising Corp. | |
CAIS Internet, Inc.
CAIS Internet, Inc. Information Technology ServicesTechnology Services CAIS Internet, Inc. is a broadband access solutions provider for hotels, apartments, and small to medium-sized businesses. The private company is based in Washington. | Technology Services |
| Digital Satellite Broadcasting Corp. | |
Lee Pharmaceuticals
 Lee Pharmaceuticals Household/Personal CareConsumer Non-Durables Lee Pharmaceuticals, Inc. provides personal care products such as cough and cold, lip balms, nasal sprays, depilatories, laxatives, oral care, quit smoking, creams, and ointments. It manufactures personal care and cosmetic products and it offers a full line of health & beauty products. The company was founded by Henry L. Lee on April 1, 1971 and is headquartered in Mobile, AL. | Consumer Non-Durables |
Mytogen, Inc.
Mytogen, Inc. BiotechnologyHealth Technology Mytogen, Inc. provides healthcare services. It focuses on using myoblasts, stem cells that form muscle, to treat patients with cardiac indications such as congestive heart failure, a progressive deterioration of the heart muscle. The company was founded in 1990 and is headquartered in Los Angeles, CA. | Health Technology |
